CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sleckman, B. G.
Right arrow Articles by Mueller, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sleckman, B. G.
Right arrow Articles by Mueller, N.

Cancer Epidemiology Biomarkers & Prevention, Vol 7, Issue 12 1117-1121, Copyright © 1998 by American Association for Cancer Research


ARTICLES

Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection

BG Sleckman, PM Mauch, RF Ambinder, R Mann, GS Pinkus, ME Kadin, B Sherburne, A Perez-Atayde, I Thior and N Mueller
Harvard Medical School, Boston, Massachusetts 02115, USA.

Risk factors suggestive of relatively late exposure to EBV have been consistently associated with Hodgkin's disease (HD) in younger adults. In addition, evidence of EBV infection has been found in the Reed-Sternberg cells themselves in about one-third to one-half of all HD cases. However, no study yet published has correlated these childhood social environment risk factors with the presence of EBV in Hodgkin's tumor cells. We examined whether EBV-positive HD occurs in those patients whose childhood environment would predispose them to relatively late exposure to EBV. The study population consisted of 102 cases of mixed cellularity (MC; n = 25) or nodular sclerosing (n = 77) HD. Samples that tested positive for either EBV-encoded RNA or latent membrane protein or both were considered EBV-positive. Of the 102 cases, 83 completed a questionnaire regarding childhood social environment. The association with EBV-positivity was estimated by the odds ratio (OR) with 95% confidence intervals (CI). Twenty-two percent of the cases were EBV-positive. These cases were more likely to be MC (OR, 6.2; CI, 2.3-16.3) and male (OR, 3.4; CI, 1.3-9.0). History of infectious mononucleosis (IM) was not predictive of EBV-positivity, with only 3 of 14 such patients being EBV-positive (P = 0.82). Contrary to our hypothesis, no association between EBV and childhood environment risk factors was identified. The association of EBV with MC histology and male gender agrees with previous reports. The most intriguing finding was the dissociation between IM history and EBV-positivity, in that almost all of the cases with a history of IM were EBV-negative.


This article has been cited by other articles:


Home page
Cancer Res.Home page
H. Hjalgrim, K. Ekstrom Smedby, K. Rostgaard, D. Molin, S. Hamilton-Dutoit, E. T. Chang, E. Ralfkiaer, C. Sundstrom, H.-O. Adami, B. Glimelius, et al.
Infectious Mononucleosis, Childhood Social Environment, and Risk of Hodgkin Lymphoma
Cancer Res., March 1, 2007; 67(5): 2382 - 2388.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. E. Kadin and C. Carpenter
Hidden identity of Hodgkin/Reed-Sternberg cells
Blood, January 1, 2004; 103(1): 7 - 7.
[Full Text] [PDF]


Home page
NEJMHome page
H. Hjalgrim, J. Askling, K. Rostgaard, S. Hamilton-Dutoit, M. Frisch, J.-S. Zhang, M. Madsen, N. Rosdahl, H. B. Konradsen, H. H. Storm, et al.
Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis
N. Engl. J. Med., October 2, 2003; 349(14): 1324 - 1332.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
H. Hjalgrim, K. Rostgaard, J. Askling, M. Madsen, H. H. Storm, C. S. Rabkin, and M. Melbye
Hematopoietic and Lymphatic Cancers in Relatives of Patients With Infectious Mononucleosis
J Natl Cancer Inst, May 1, 2002; 94(9): 678 - 681.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
F. E. Alexander, R. F. Jarrett, R. A. Cartwright, A. A. Armstrong, D. A. Gokhale, E. Kane, D. Gray, D. J. Lawrence, and G. M. Taylor
Epstein-Barr Virus and HLA-DPB1-*0301 in Young Adult Hodgkin's Disease: Evidence for Inherited Susceptibility to Epstein-Barr Virus in Cases that Are EBV+ve
Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 705 - 709.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y. Yasui, J. D. Potter, J. L. Stanford, M. A. Rossing, M. D. Winget, M. Bronner, and J. Daling
Breast Cancer Risk and "Delayed" Primary Epstein-Barr Virus Infection
Cancer Epidemiol. Biomarkers Prev., January 1, 2001; 10(1): 9 - 16.
[Abstract] [Full Text]


Home page
JNCI J Natl Cancer InstHome page
H. Hjalgrim, J. Askling, P. Sorensen, M. Madsen, N. Rosdahl, H. H. Storm, S. Hamilton-Dutoit, L. S. Eriksen, M. Frisch, A. Ekbom, et al.
Risk of Hodgkin's Disease and Other Cancers After Infectious Mononucleosis
J Natl Cancer Inst, September 20, 2000; 92(18): 1522 - 1528.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1998 by the American Association for Cancer Research.